Sentien Co-Founder Dr. Biju Parekkadan to Speak at American Society of Gene & Cell Therapy Annual Meeting on 4/29
Filter: PRESS RELEASES IN THE NEWS EVENTS
Sentien Co-Founder Dr. Biju Parekkadan to Speak at American Society of Gene & Cell Therapy Annual Meeting on 4/29
Sentien Biotechnologies Scientific Co-Founder, Dr. Biju Parekkadan, will be speaking at the American Society of Gene & Cell Therapy Annual Meeting on April 29, 2019 in Washington, DC. He will be discussing Reprogramming Human Immune Responses Using Ex Vivo MSC Bioreactor Therapy.
